These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19212925)

  • 1. Predictors of methamphetamine injection in out-of-treatment IDUs.
    Corsi KF; Kwiatkowski CF; Booth RE
    Subst Use Misuse; 2009; 44(3):332-42. PubMed ID: 19212925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk practices associated with bacterial infections among injection drug users in Denver, Colorado.
    Phillips KT; Stein MD
    Am J Drug Alcohol Abuse; 2010 Mar; 36(2):92-7. PubMed ID: 20337504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran.
    Mehrjerdi ZA; Abarashi Z; Noroozi A; Arshad L; Zarghami M
    Int J STD AIDS; 2014 May; 25(6):420-7. PubMed ID: 24287028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users.
    Kwiatkowski CF; Fortuin Corsi K; Booth RE
    Addiction; 2002 Oct; 97(10):1289-94. PubMed ID: 12359033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with infection of blood-borne virus among people who used methamphetamine.
    Cai Y; Dai Z; Wen S; Bhandari R
    BMC Infect Dis; 2020 Oct; 20(1):742. PubMed ID: 33036558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual and injection risk among women who inject methamphetamine in San Francisco.
    Lorvick J; Martinez A; Gee L; Kral AH
    J Urban Health; 2006 May; 83(3):497-505. PubMed ID: 16739050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of additional injection-related HIV risk behaviors among injection drug users.
    Koester S; Booth RE; Zhang Y
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):202-7. PubMed ID: 8680893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of HIV testing among young methamphetamine users in Muse, Northern Shan State, Myanmar.
    Saw YM; Poudel KC; Kham NP; Chan N; Cope JE; Wai KM; Tun S; Saw TN
    BMC Public Health; 2014 Jul; 14():735. PubMed ID: 25042697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection among methamphetamine-dependent individuals in outpatient treatment.
    Gonzales R; Marinelli-Casey P; Shoptaw S; Ang A; Rawson RA
    J Subst Abuse Treat; 2006 Sep; 31(2):195-202. PubMed ID: 16919748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
    Moradi G; Hajarizadeh B; Rahmani K; Mohamadi-Bolbanabad A; Darvishi S; Zareie B; Zavareh FA; Sharafi H; Alavian SM; Ramazani R; Eftekhar M; Radfar SR; Piroozi B; Gouya MM
    Int J Drug Policy; 2019 Nov; 73():129-134. PubMed ID: 31654935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heroin and Methamphetamine Injection: An Emerging Drug Use Pattern.
    Al-Tayyib A; Koester S; Langegger S; Raville L
    Subst Use Misuse; 2017 Jul; 52(8):1051-1058. PubMed ID: 28323507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users.
    Molitor F; Ruiz JD; Flynn N; Mikanda JN; Sun RK; Anderson R
    Am J Drug Alcohol Abuse; 1999 Aug; 25(3):475-93. PubMed ID: 10473010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-reported hepatitis C virus antibody status and risk behavior in young injectors.
    Hagan H; Campbell J; Thiede H; Strathdee S; Ouellet L; Kapadia F; Hudson S; Garfein RS
    Public Health Rep; 2006; 121(6):710-9. PubMed ID: 17278406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low knowledge and perceived Hepatitis C risk despite high risk behaviour among injection drug users in Kathmandu, Nepal.
    Loewinger G; Sharma B; Karki DK; Khatiwoda P; Kainee S; Poudel KC
    Int J Drug Policy; 2016 Jul; 33():75-82. PubMed ID: 27318773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polydrug Use and HIV Risk Among People Who Inject Heroin in Tijuana, Mexico: A Latent Class Analysis.
    Meacham MC; Rudolph AE; Strathdee SA; Rusch ML; Brouwer KC; Patterson TL; Vera A; Rangel G; Roesch SC
    Subst Use Misuse; 2015; 50(10):1351-9. PubMed ID: 26444185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic, HIV risk behavior, and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities.
    Buchanan D; Tooze JA; Shaw S; Kinzly M; Heimer R; Singer M
    Drug Alcohol Depend; 2006 Feb; 81(3):221-9. PubMed ID: 16171952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks.
    De P; Cox J; Boivin JF; Platt RW; Jolly AM
    J Acquir Immune Defic Syndr; 2007 Nov; 46(3):355-61. PubMed ID: 17721398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago.
    Boodram B; Golub ET; Ouellet LJ
    Drug Alcohol Depend; 2010 Sep; 111(1-2):136-45. PubMed ID: 20472373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada.
    Cunningham EB; Jacka B; DeBeck K; Applegate TL; Harrigan PR; Krajden M; Marshall BD; Montaner J; Lima VD; Olmstead AD; Milloy MJ; Wood E; Grebely J
    Drug Alcohol Depend; 2015 Jul; 152():272-6. PubMed ID: 25977204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.